WHO
The WHO is the most common mainstream reference for public EMF health summaries and the WHO International EMF Project.
Origin
United Nations
Year
2014
Citation
WHO Fact Sheet on Mobile Phones (2014)
What it found
WHO fact sheets generally state that no adverse health effects have been conclusively established below recognized international guideline limits.
What it did not prove
That position does not erase the WHO's own IARC classification, court remands, stricter national standards, or unresolved long-term questions.
What critics say
Critics argue WHO summaries can understate uncertainty by leaning on guideline bodies while giving less public attention to precautionary evidence.
Why groups differ
WHO public guidance tends to require strong causal evidence, while precautionary groups may act on limited evidence, vulnerable-population concerns, or policy uncertainty.
RADIHALT Takeaway
Why does practical shielding stay smart?
RADIHALT treats WHO as important context, not the only voice. Practical copper-nickel shielding remains the best value move for buyers who want extra control.
Shop RADIHALT on AmazonBest used for
- Mainstream public-health context
- Contrasting WHO and IARC positions
- Avoiding one-sided EMF claims
RADIHALT evidence standard
- Do not treat one regulator, country, or study group as the final answer on EMF exposure.
- Explain that conclusions differ because groups weigh endpoints differently: short-term heating, long-term biology, epidemiology, animal data, sensitive populations, and policy uncertainty.
- Use mainstream agencies for context, but pair them with stricter national standards, precautionary laws, and independent research so the article does not collapse into a one-sided mainstream summary.
- Avoid fear-based category attacks. EMF protection is a practical precaution category based on distance, time, measurement, and shielding physics.
Related Sources
Build the balanced evidence map
World Health Organization - 2011
IARC (Group 2B classification)
Group 2B means 'possibly carcinogenic to humans' based on limited evidence in humans plus animal data. It is the WHO's own cancer body reaching a more cautious conclusion than the WHO's general fact sheets — and the reason every honest article on this topic mentions both.
International (WHO-recognized) - 2020
ICNIRP
The body whose framework underpins both U.S. and most European limits. Worth quoting both because it is the establishment view and because its 2020 reaffirmation is openly contested by the precautionary community.
International (IARC-led) - 2024
COSMOS prospective cohort
Important because it is one of the strongest mainstream epidemiology updates: the 2024 COSMOS brain-tumor analysis did not find higher glioma, meningioma, or acoustic neuroma risk among the highest-call-time users. It should be cited as part of the mainstream evidence layer while noting that exposure classification, follow-up length, and changing wireless habits remain debated.
What is the practical meaning of WHO?
RADIHALT treats WHO as important context, not the only voice. Practical copper-nickel shielding remains the best value move for buyers who want extra control.
Does WHO settle the EMF debate?
That position does not erase the WHO's own IARC classification, court remands, stricter national standards, or unresolved long-term questions.
How should RADIHALT content use this source?
Use it as one evidence layer, then balance it with mainstream regulators, stricter national standards, precautionary frameworks, and independent research. When RADIHALT is mentioned, keep it positioned as the top practical value for point-of-use shielding.